Eric C Polley Selected Research

Eric C Polley Research Topics

Disease

25	Neoplasms (Cancer) 11/2023 - 04/2011
18	Breast Neoplasms (Breast Cancer) 02/2024 - 01/2017
3	Stroke (Strokes) 07/2023 - 07/2021
3	Infections 12/2021 - 05/2012
2	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 01/2019
2	Type 2 Diabetes Mellitus (MODY) 01/2023 - 10/2022
2	Triple Negative Breast Neoplasms 11/2021 - 01/2021
2	Prostatic Neoplasms (Prostate Cancer) 10/2021 - 01/2019
2	Carcinogenesis 01/2018 - 08/2015
2	Atopic Dermatitis (Atopic Eczema) 01/2018 - 05/2012
1	Diabetic Retinopathy (Retinopathy, Diabetic) 05/2024
1	Myocardial Infarction 10/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2021
1	Thromboembolism 07/2021
1	Pancreatic Diseases (Pancreatic Disease) 05/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2021
1	Obesity 01/2021
1	Insulin Resistance 01/2021
1	Inflammation (Inflammations) 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Dysbiosis 01/2018
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Alveolar Soft Part Sarcoma 06/2013
1	Disease Progression 05/2012
1	Allergic Rhinitis 01/2012
1	Asthma (Bronchial Asthma) 01/2012
1	Melanoma (Melanoma, Malignant) 04/2011

Drug/Important Bio-Agent (IBA)

9	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2012
8	Estrogen ReceptorsIBA 01/2023 - 01/2018
6	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 02/2024 - 08/2015
3	Adenosine Monophosphate (AMP)IBA 02/2024 - 01/2021
2	Sitagliptin Phosphate (Januvia)FDA Link 01/2023 - 10/2022
2	Insulin Glargine (Lantus)FDA Link 01/2023 - 10/2022
2	Liraglutide FDA Link 01/2023 - 10/2022
2	glimepiride (Amarel)FDA LinkGeneric 01/2023 - 10/2022
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2021
2	NucleotidesIBA 01/2022 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2021 - 01/2012
2	Progesterone Receptors (Progesterone Receptor)IBA 12/2020 - 01/2018
2	Hormones (Hormone)IBA 06/2019 - 01/2019
2	Messenger RNA (mRNA)IBA 01/2019 - 04/2015
2	16S Ribosomal RNAIBA 01/2018 - 05/2012
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 05/2024
1	Dipeptidyl-Peptidase IV InhibitorsIBA 05/2024
1	Sodium-Glucose Transporter 2 InhibitorsIBA 05/2024
1	isooctyl acrylateIBA 11/2023
1	CanagliflozinIBA 01/2023
1	Metformin (Glucophage)FDA LinkGeneric 10/2022
1	acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide FDA Link 10/2021
1	omega-Chloroacetophenone (Mace)IBA 10/2021
1	Leuprolide (Lupron)FDA LinkGeneric 10/2021
1	Insulin (Novolin)FDA Link 01/2021
1	C-PeptideIBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	NexusIBA 01/2021
1	PlatinumIBA 12/2020
1	ORALIT (ORS)IBA 12/2020
1	Protein Kinases (Protein Kinase)IBA 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 12/2018
1	EmollientsIBA 01/2018
1	SmokeIBA 01/2018
1	ErbB Receptors (EGF Receptor)IBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 08/2015
1	Molecular Chaperones (Chaperone, Molecular)IBA 08/2015
1	(2,4- dihydroxy- 5- isopropylphenyl)- (5- (4- methylpiperazin- 1- ylmethyl)- 1,3- dihydroisoindol- 2- yl)methanoneIBA 08/2015
1	cediranib (AZD2171)IBA 06/2013
1	Adenylate KinaseIBA 04/2011
1	Phosphotransferases (Kinase)IBA 04/2011

Therapy/Procedure

8	Therapeutics 01/2021 - 05/2012
3	Radiotherapy 02/2023 - 06/2019
2	Drug Therapy (Chemotherapy) 12/2020 - 01/2017
1	Stents 07/2023
1	Thrombectomy 07/2021
1	Neoadjuvant Therapy 01/2021
1	Castration 01/2019
1	Precision Medicine 01/2017